Diabetes Corporation of America dba DCA Pharmacy

FDA Regulatory Profile

Diabetes Corporation of America dba DCA Pharmacy appears in FDA public data with 1 recall, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0006-2016, Class II) was initiated on September 23, 2015.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0006-2016Class IISermorelin 6mg/6mL Lyophilized Powder, Sterile Compound for Subcutaneous Injection, Diabetes CorporaSeptember 23, 2015